2K1Q

NMR structure of hepatitis c virus ns3 serine protease complexed with the non-covalently bound phenethylamide inhibitor

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D HNCO	0.6 mM [U-100% 13C; U-100% 15N] NS3 PROTEASE, 50 uM ZINC ION, 0.6 mM phenetylamide, 50 % sodium phosphate, 0.3 mM [U-100% 2H] beta-octilglucoside, 100 mM sodium chloride, 1 mM DTT	95% H2O/5% D2O	0.15	6.8	ambient	308
2	3D HNCA	0.6 mM [U-100% 13C; U-100% 15N] NS3 PROTEASE, 50 uM ZINC ION, 0.6 mM phenetylamide, 50 % sodium phosphate, 0.3 mM [U-100% 2H] beta-octilglucoside, 100 mM sodium chloride, 1 mM DTT	95% H2O/5% D2O	0.15	6.8	ambient	308
3	3D HN(CO)CA	0.6 mM [U-100% 13C; U-100% 15N] NS3 PROTEASE, 50 uM ZINC ION, 0.6 mM phenetylamide, 50 % sodium phosphate, 0.3 mM [U-100% 2H] beta-octilglucoside, 100 mM sodium chloride, 1 mM DTT	95% H2O/5% D2O	0.15	6.8	ambient	308
4	3D CBCA(CO)NH	0.6 mM [U-100% 13C; U-100% 15N] NS3 PROTEASE, 50 uM ZINC ION, 0.6 mM phenetylamide, 50 % sodium phosphate, 0.3 mM [U-100% 2H] beta-octilglucoside, 100 mM sodium chloride, 1 mM DTT	95% H2O/5% D2O	0.15	6.8	ambient	308
5	3D HCCH-TOCSY	0.6 mM [U-100% 13C; U-100% 15N] NS3 PROTEASE, 50 uM ZINC ION, 0.6 mM phenetylamide, 50 % sodium phosphate, 0.3 mM [U-100% 2H] beta-octilglucoside, 100 mM sodium chloride, 1 mM DTT	95% H2O/5% D2O	0.15	6.8	ambient	308
6	3D HCCH-COSY	0.6 mM [U-100% 13C; U-100% 15N] NS3 PROTEASE, 50 uM ZINC ION, 0.6 mM phenetylamide, 50 % sodium phosphate, 0.3 mM [U-100% 2H] beta-octilglucoside, 100 mM sodium chloride, 1 mM DTT	95% H2O/5% D2O	0.15	6.8	ambient	308
7	3D 1H-13C NOESY	0.6 mM [U-100% 13C; U-100% 15N] NS3 PROTEASE, 50 uM ZINC ION, 0.6 mM phenetylamide, 50 % sodium phosphate, 0.3 mM [U-100% 2H] beta-octilglucoside, 100 mM sodium chloride, 1 mM DTT	95% H2O/5% D2O	0.15	6.8	ambient	308
8	3D 1H-15N NOESY	0.9 mM [U-100% 15N] NS3 PROTEASE, 50 uM ZINC ION, 0.9 mM phenetylamide, 50 mM sodium phosphate, 0.3 % [U-100% 2H] beta-octilglucoside, 100 mM sodium chloride, 1 mM DTT	95% H2O/5% D2O	0.15	6.8	ambient	308
9	3D 1H-15N TOCSY	0.9 mM [U-100% 15N] NS3 PROTEASE, 50 uM ZINC ION, 0.9 mM phenetylamide, 50 mM sodium phosphate, 0.3 % [U-100% 2H] beta-octilglucoside, 100 mM sodium chloride, 1 mM DTT	95% H2O/5% D2O	0.15	6.8	ambient	308

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	700
2	Bruker	AVANCE	600
3	Bruker	AVANCE	500
4	Bruker	AVANCE	400

NMR Refinement
Method	Details	Software
simulated annealing		XwinNMR

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	XwinNMR		Bruker Biospin
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	data analysis	NMRView		Johnson, One Moon Scientific
4	refinement	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.